Skin testing using a commercially available benzylpenicilloyl polylysine conjugate may be used to predict the likeli-hood of an immediate-type reactions. Skin testing cannot predict non-IgE-mediated reactions; therefore, a thorough history to determine the necessity for skin testing is important.